Lida A. Mina is an expert in the field of Hematology. He went to medical school at Indiana University School of Medicine. Indiana University School of Medicine is ranked 45 in research and 47 in primary care medicine Lida Mina is a published MD. He published 7 publications, including: 'A phase II study of combined VEGF inhibitor (bevacizumab+sorafenib) in patients with metastatic breast cancer: Hoosier Oncology Group Study BRE06-109.' Lida A. Mina accepts Medicare payments and is registered with Medicare.gov.
NPI NUMBER | 1568625077 | |
NPPES Provider LastName | MINA | |
NPPES Provider FirstName | LIDA | |
NPPES Provider ZIPCode | 462025116 | |
NPPES Provider State | IN | |
Specialty Description | Hematology/Oncology | |
Total Claim Count | 507.0 | |
Distinct Opioid Count | 1.0 | |
Opioid Claim Count | 19.0 | |
Percent Opioid Claims | 3.75 |
National Provider Identifier [NPI] | 1568625077 |
Last Name Of The Provider | MINA |
First Name Of The Provider | LIDA |
View All |
Dr. Lawrence H. Einhorn, MD
This Doctor is OpenDoctor Recommended. This doctor has more publications |
|
Dr. H S. Boswell Jr., MD
This Doctor is OpenDoctor Recommended. This doctor has more publications |
|
Dr. Rashmi Ramasubbaiah, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. John T. Brandt, MD | |
Dr. David P. Gray, MD | |
Dr. Richard A. Walgren, MD | |
Dr. Datchen F. Tai, MD
This Doctor is OpenDoctor Recommended. This doctor has more publications |
|
Dr. Shivani Srivastava, MD
This Doctor is OpenDoctor Recommended. This doctor has more publications |
|
Dr. Travis J. Osterman, DO |